Srinath Palakurthi
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems 8
- Drug Solubulity and Delivery Systems 7
- Advancements in Transdermal Drug Delivery 3
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery 7
- Polymers and Plastics top 5%
- Dendrimers and Hyperbranched Polymers 7
- Molecular Medicine top 5%
- Drug Discovery top 10%
-
- RNA Interference and Gene Delivery 11
- Advanced biosensing and bioanalysis techniques 5
-
- PARP inhibition in cancer therapy 3
- Co-authors
- Rishi PaliwalVenkata YellepeddiR. Jayachandra BabuAjay KumarKiran Kumar VangaraNeelesh Kumar MehraSushesh Srivatsa PalakurthiBrijesh Shah
- Journals
- International Journal of Pharmaceutics (6 papers)AAPS PharmSciTech (3 papers)Expert Opinion on Drug Delivery (3 papers)
- Partner nations
- United StatesIndiaChile
In The Last Decade
Srinath Palakurthi
42 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 124
- Pharmaceutical Science 383
- Biomaterials 634
- Polymers and Plastics 225
- Molecular Medicine 79
- Drug Discovery 2
Countries citing papers authored by Srinath Palakurthi
This map shows the geographic impact of Srinath Palakurthi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Srinath Palakurthi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Srinath Palakurthi more than expected).
Fields of papers citing papers by Srinath Palakurthi
This network shows the impact of papers produced by Srinath Palakurthi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Srinath Palakurthi. The network helps show where Srinath Palakurthi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Srinath Palakurthi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 21 | |
| 5 | A comprehensive review of challenges and advances in exosome-based drug delivery systemsbreakdown → | 2024 | 74 |
| 6 | 2023 | 15 | |
| 7 | 2023 | 4 | |
| 8 | 2022 | 8 | |
| 9 | 2021 | 16 | |
| 10 | 2020 | 68 | |
| 11 | 2018 | 16 | |
| 12 | 2015 | 140 | |
| 13 | 2015 | 83 | |
| 14 | Zein in controlled drug delivery and tissue engineeringbreakdown → | 2014 | 413 |
| 15 | 2014 | 32 | |
| 16 | 2012 | 6 | |
| 17 | 2011 | 9 | |
| 18 | 2010 | 37 | |
| 19 | 2009 | 70 | |
| 20 | 2008 | 20 |
About Srinath Palakurthi
Srinath Palakurthi is a scholar working on Pharmaceutical Science, Biomaterials and Polymers and Plastics, having authored 44 papers that have together received 2.1k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (11 papers), Advanced Drug Delivery Systems (8 papers), Drug Solubulity and Delivery Systems (7 papers), Nanoparticle-Based Drug Delivery (7 papers), Dendrimers and Hyperbranched Polymers (7 papers), Advanced biosensing and bioanalysis techniques (5 papers), PARP inhibition in cancer therapy (3 papers) and Advancements in Transdermal Drug Delivery (3 papers). The work is most often cited by research in Pharmaceutical Science (383 citations), Biomaterials (634 citations) and Polymers and Plastics (225 citations). Srinath Palakurthi has collaborated with scholars based in United States, India and Chile. Frequent co-authors include Rishi Paliwal, Venkata Yellepeddi, R. Jayachandra Babu, Ajay Kumar, Kiran Kumar Vangara, Neelesh Kumar Mehra, Sushesh Srivatsa Palakurthi, Brijesh Shah, Jingbo Louise Liu and Sharad Khare. Their work appears in journals such as International Journal of Pharmaceutics, AAPS PharmSciTech, Expert Opinion on Drug Delivery, Cancer Letters and Bioengineering & Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.